SCHEMBL4667036

SCHEMBL4667036

CCc1nn(-c2ccccn2)c(Nc2ccc(Cl)cc2C(=O)O)c1-c1ccc(OC)nc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 13/20 0.46
MEN1 O00255 1/20 0.42
USP2 O75604 1/20 0.42
PABPC1 P11940 1/20 0.42
KMT2A Q03164 1/20 0.42
ADORA2A P29274 1/20 0.41
ADORA2B P29275 1/20 0.41
ADORA3 P0DMS8 1/20 0.40
MARS1 P56192 1/20 0.39
KDM4E B2RXH2 2/20 0.38
ALDH1A1 P00352 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
FFAR4 Q5NUL3 1/20 0.37
PRKAG1 P54619 1/20 0.37
PRKAA1 Q13131 1/20 0.37
PRKAB1 Q9Y478 1/20 0.37
HPGD P15428 1/20 0.37
FABP3 P05413 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14600188 0.87 ADORA1 (0.44) ADORA1MEN1USP2PABPC1KMT2A
SCHEMBL4668599 0.80 ADORA1 (0.50) ADORA1ADORA2AADORA2BADORA3
SCHEMBL5007765 0.79 ADORA1 (0.68) ADORA1ADORA2AADORA2BADORA3
SCHEMBL14600204 0.78 ADORA1 (0.47) ADORA1ADORA2AADORA2BADORA3
SCHEMBL14600200 0.77 ADORA1 (0.51) ADORA1ADORA2AADORA2BADORA3
SCHEMBL14600704 0.76 ADORA1 (0.46) ADORA1ADORA2AADORA2BADORA3CYP1A2
SCHEMBL14600645 0.76 ALDH1A1 (0.41) ADORA1MEN1KMT2AMARS1KDM4E
SCHEMBL4633959 0.76 ADORA1 (0.44) ADORA1ADORA2AADORA2BHPGDFABP3
SCHEMBL14600247 0.75 ADORA1 (0.43) ADORA1ADORA2AADORA2BADORA3
SCHEMBL4668225 0.74 ADORA1 (0.44) ADORA1ADORA2AADORA2BMARS1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1928455-A1 ANILINOPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES Bayer Healthcare, LLC (US) 2008-06-11 EP disclosed
WO-2007027842-A1 ANILINOPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES BAYER HEALTHCARE LLC (US) 2007-03-08 WO disclosed
WO-2007027842-A1 ANILINOPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES BAYER HEALTHCARE LLC (US) 2007-03-08 WO disclosed